ChinaAMC reduced its holdings of CSPC PHARMA (01093) by 9,824,000 shares, at a price of approximately HK$7.45 per share.
On May 19, Haitong Fund Management Co., Ltd. reduced its holdings of China Resources Pharmaceutical Group Limited (01093) by 9.824 million shares, with a price of 7.4527 Hong Kong dollars per share, resulting in a total amount of approximately 73.2153 million Hong Kong dollars.
The latest data from the Hong Kong Stock Exchange shows that on May 19th, Haitong Fund Management Co., Ltd. reduced its holdings of CSPC PHARMA (01093) by 9.824 million shares, at a price of 7.4527 Hong Kong dollars per share, with a total amount of approximately 73.2153 million Hong Kong dollars. After the reduction, the new holding number is approximately 570 million shares, with a shareholding proportion of 4.95%.
Related Articles
New IPO news: Xiangdao Travel submitted a second application to the Hong Kong Stock Exchange, attracting key industry chain investors such as Momenta, Gaode, and Contemporary Amperex Technology.
New Stock News | Innovative biopharmaceutical company Sinocelltech Inc. (688520.SH) files for listing on the Hong Kong Stock Exchange with a gross profit margin of over 90% for three consecutive years.
New stock news | EROAD Travel's secondary listing on the Hong Kong Stock Exchange
New IPO news: Xiangdao Travel submitted a second application to the Hong Kong Stock Exchange, attracting key industry chain investors such as Momenta, Gaode, and Contemporary Amperex Technology.
New Stock News | Innovative biopharmaceutical company Sinocelltech Inc. (688520.SH) files for listing on the Hong Kong Stock Exchange with a gross profit margin of over 90% for three consecutive years.
New stock news | EROAD Travel's secondary listing on the Hong Kong Stock Exchange
